Cargando…
AWARE A novel web application to rapidly assess cardiovascular risk in type 2 diabetes mellitus
AIM: To describe the development of the AWARE App, a novel web application for the rapid assessment of cardiovascular risk in Type 2 Diabetes Mellitus (T2DM) patients. We also tested the feasibility of using this App in clinical practice. METHODS: Based on 2019 European Society of Cardiology/Europea...
Autores principales: | Berra, Cesare, Manfrini, Roberto, Mirani, Marco, Bucciarelli, Loredana, Zakaria, Ahmed S., Piccini, Sara, Ghelardi, Renata, Lunati, Maria Elena, Rodovalho, Sylka, Bifari, Francesco, Fiorina, Paolo, Folli, Franco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359387/ https://www.ncbi.nlm.nih.gov/pubmed/37270748 http://dx.doi.org/10.1007/s00592-023-02115-x |
Ejemplares similares
-
Time-dependent effect of GLP-1 receptor agonists on cardiovascular benefits: a real-world study
por: Piccini, Sara, et al.
Publicado: (2023) -
Real world effectiveness of subcutaneous semaglutide in type 2 diabetes: A retrospective, cohort study (Sema-MiDiab01)
por: Berra, Cesare C., et al.
Publicado: (2023) -
Biliopancreatic Diversion (BPD), Long Common Limb Revisional Biliopancreatic Diversion (BPD + LCL–R), Roux-en-Y Gastric Bypass [RYGB] and Sleeve Gastrectomy (SG) mediate differential quantitative changes in body weight and qualitative modifications in body composition: a 5-year study
por: Ceriani, Valerio, et al.
Publicado: (2021) -
REL-1017 (Esmethadone), A Novel NMDAR Blocker for the Treatment of MDD is Not Neurotoxic in Sprague-Dawley Rats
por: Bifari, Francesco, et al.
Publicado: (2022) -
REL-1017 (Esmethadone) Increases Circulating BDNF Levels in Healthy Subjects of a Phase 1 Clinical Study
por: De Martin, Sara, et al.
Publicado: (2021)